Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 764 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

Oxford and GSK launch Experimental Medicine Collaboration

GSK invests £10 million over five years to establish the Experimental Medicine Collaboration with the University of Oxford.

Two Oxford academics receive ERC Synergy Grants to tackle major scientific challenges

Two Oxford University academics are to co-lead ambitious new research projects backed by European Research Council (ERC) Synergy Grants, part of the EU’s Horizon Europe research and innovation programme. Synergy Grants foster collaboration between outstanding researchers, enabling them to combine their expertise, knowledge and resources to push the boundaries of scientific discovery.

World’s first lung cancer prevention vaccine gets £2 million for clinical trial

People at high risk of lung cancer will soon be able to receive the first-ever experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial. The LungVax vaccine carries a series of genetic instructions which train the immune system to recognise tumour antigens on the surface of abnormal lung cells.

Study reveals how drug resistance develops early in targeted AML therapy

A new study led by researchers at the MRC Molecular Haematology Unit has shown that resistance to a targeted treatment for acute myeloid leukaemia (AML) can develop much earlier than expected.

Shaping immunity - the secrets behind the shape of neutrophils

Researchers at the Kennedy Institute have provided the most comprehensive overview to date of how the distinctive segmented nucleus of neutrophils influences their function in health and disease.

Tobacco deaths: the past 75 and the next 75, a guest lecture with Professor Sir Richard Peto

Leading researchers from the Nuffield Department of Primary Care Health Sciences and Nuffield Department of Population Health came together this week for a special event highlighting the enduring impact of research into tobacco addiction and public health.

Oxford researchers awarded funding to pioneer ovarian cancer vaccine development

Ovarian cancer remains a devastating global health challenge: each year, over 300,000 women are diagnosed, and nearly 200,000 lives are lost, largely because the disease is detected at a late stage. Women carrying inherited genetic changes face a significantly elevated lifetime risk, over 40%, and current preventive strategies often require invasive surgery that compromises fertility. These limitations underscore an urgent need for non-surgical preventive options, and vaccines could offer a groundbreaking solution.

Iron supplement absorption preserved in children with HIV and boosted by prebiotics

New research shows that iron from supplements and fortified foods is well-absorbed in children living with virally suppressed HIV, and that administering iron supplements with prebiotics may enhance their effectiveness and improve their safety.

Oxford scientists map the cells that drive Crohn’s disease fistulas

Researchers at the MRC Translational Immune Discovery Unit have identified how rare populations of abnormal cells drive the formation and persistence of fistulas - painful, tunnel-like tracts that develop in around 30% of people with Crohn’s disease - paving the way for targeted treatments.

Oxford joins £15.9m national initiative to transform cancer research using live human tissue models

Oxford scientists are part of a new £15.9 million UK initiative to transform disease research through the development of advanced human tissue models. The INTREPID project will evaluate and optimise the use of live human tumour samples to enhance the accuracy of preclinical research, speed up drug discovery, and reduce dependence on animal testing.

Shame a significant factor in hairpulling in young people, new study finds

It found that shame partially explained the relationship between hairpulling and depression, and fully explained the relationship between hairpulling and anxiety.

From pain to policy: global reviews call for urgent action on endometriosis in most world regions

First global mapping shows half the world’s countries lack policies or guidelines for endometriosis, affecting >200 million women and girls.

Oxford scientists capture genome’s structure in unprecedented detail

Radcliff Department of Medicine scientists have achieved the most detailed view yet of how DNA folds and functions inside living cells, revealing the physical structures that control when and how genes are switched on.

New Microbiome Innovation Network to drive UK Bioscience Research

Researchers from the Kennedy Institute are part of a UK-wide consortium that has been awarded a £644K BBSRC Network Grant to establish the Microbiome Innovation Network (Microbiome-Net).

New study to investigate link between gut microbiome and emotional and cognitive wellbeing in early menopause

The research will add to a growing body of evidence on the effects of probiotics on mood and cognition and their ability to positively affect menopausal symptoms.

Symposium honours the life and legacy of Professor Tipu Aziz

The Nuffield Department of Surgical Sciences (NDS) hosted a special symposium on Friday 17 October 2025 in honour of Professor Tipu Aziz (1956–2024), Emeritus Professor of Neurosurgery and founder and head of Oxford Functional Neurosurgery.

New research published: How the brain conquers the third dimension

Members of the Department of Physiology, Anatomy and Genetics (DPAG) are part of an international collaborative team that has published new research in Proceedings of the National Academy of Sciences.

The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences enhances surgical research capacity in Vietnam

Prof David Beard was the keynote speaker at a recent Surgical Trials Workshop in Ho Chi Minh City, Vietnam, contributing to improved treatment quality and greater international integration in healthcare and medical science.

New AI tool could improve prostate cancer treatment

A ground-breaking new study will test how artificial intelligence (AI) can make prostate cancer diagnosis more accurate. The study by the University of Oxford is funded by a £1.9m grant from research charity Prostate Cancer UK.

Terumo completes acquisition of University of Oxford spinout OrganOx for a record $1.5bn

OrganOx, a pioneering Oxford University spinout transforming kidney and liver transplantation, has been fully acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo, Japan, for US$1.5 billion, marking the largest exit in Oxford University’s spinout portfolio to date and the first in excess of £1bn. The agreement for the acquisition was announced in August 2025.

Load More